 Codexis, Inc. NASDAQ: CDXS has appointed Dr. Stephen Dilly, Board member, and biotechnology veteran, as President and CEO, effective August 9, 2022. After ten years of leading the transformation and growth of Codexis, the current President and CEO, John Nicols, will step down for. 